一种可变的血红蛋白临床表现 希望之城
Dafna Brik Simon1, Dvora Filon2, Vardiella Meiner3,4
1Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Clinical genetics
|December 19, 2024
概括
血红蛋白希望之城 (Hb-COH) 似乎无症状,即使在同卵同卵的个体. 然而,当与其他β-环球蛋白变体一起遗传时,它可能会导致严重的贫血,影响患者的治疗.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 血红蛋白希望之城 (Hb-COH) 是一种罕见的血红蛋白变体.
- 它的临床表现没有很好的特征,从无症状到严重的贫血.
研究的目的:
- 为了阐明Hb-COH.的临床光谱.
- 为了分析Hb-COH的个体,包括同卵性病例.
主要方法:
- 对携带Hb-COH变异的31个人进行分析.
- 评估临床表现,包括贫血,血红蛋白水平和共同遗传的遗传变异.
- 追溯Hb-COH等位基因的起源.
主要成果:
- 孤立的Hb-COH是无症状的,即使在同卵性个体 (n=3) 中也是如此.
- 与另一种β-环球蛋白变异体 (n=7) 的化合物异构体显示出轻度至重度的微细胞性贫血.
- 与α-3.7删除 (n=7) 共同继承导致从轻度贫血到正常血细胞计数的频谱.
- 大多数可追溯的Hb-COH等位基因来源于阿什基纳兹犹太人 (70.4%).
结论:
- 孤立的Hb-COH通常无症状.
- 与其他致病性β-环球蛋白变体的共同遗传会导致显著的贫血.
- 了解Hb-COH的影响对于患者管理和遗传咨询至关重要.
相关概念视频
Multiple Allele Traits
The Concept of Multiple Allelism
Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


